dm+d

Unassigned

New Medicines

Iomab-BAcute myeloid leukaemia (AML) - pre-hematopoietic stem cell transplant

Information

Iomab-B
New molecular entity
Actinium
Actinium

Development and Regulatory status

None
None
Phase III Clinical Trials
Yes
Yes

Category

Radioimmunoconjugate consisting of BC8, a novel murine monoclonal antibody targeting CD45, a pan-leukocytic antigen, and iodine 131 radioisotope.
AML affects < 1.2 in 10,000 people in the EU (equivalent to not more than 61,000 people).
Acute myeloid leukaemia (AML) - pre-hematopoietic stem cell transplant
Intravenous